Drugs becoming eligible for first Paragraph IV ANDA filing in 2031
Drugs expiring in 2032
Drugs that contains Edoxaban Tosylate
Cabazitaxel patents expiration
Drugs that contains Trabectedin
St Renatus patents expiration
Drugs that contains Carfilzomib
Drugs that contains Seladelpar Lysine
